@umasschan-bmb.bsky.social

✅ ID new citrullination site in NF-kB p65 ✅ Show macrophage polarization is decreased when citrullination enzyme PAD2 is gone ✅ Develop a nanomedicine: gold nanoparticles + PAD2 inhibitor + ICAM-1 ✅ Show reduction of inflammation in acute lung injury syndrome 🧪 pubmed.ncbi.nlm.nih.gov/40087815/

a complex infographic showing the proposed mechanism of action for the nanomedicine developed in this publication. in untreated cells, treatment with LPS increases ICAM-1 expression while simultaneously activating nfkb p65 signaling (this process is partly regulated by citrullination enzyme PAD2). in treated cells, the nanomedicine (covered in ICAM-1 antibodies) binds to ICAM-1 and is taken up by the cell. a PAD2 inhibitor is released inside the cell and reduces PAD2 activity, which therefore reduces nfkb p65 signaling.

Sean Ryder, PhD, professor of biochemistry & molecular biotechnology, makes the case for NIH funding in this editorial: direc.to/mMoW “Gutting the NIH will harm those who stand to benefit from new, lifesaving therapies derived from NIH-funded research.” #NIHfunding @umasschan-bmb.bsky.social

Opinion/Guest column: Gutting NIH a disaster in the making for research, local economy

Less research equates to less business between the university and these Worcester companies, spreading the pain far beyond campus borders.

direc.to